Basic Sciences

July 20, 2017

Study identifies protein’s role in chemotherapy resistance

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.

By Bill Snyder
July 20, 2017

Shyr named chair of Department of Biostatistics

Yu Shyr, Ph.D., Harold L. Moses Professor of Cancer Research and director of the Vanderbilt Center for Quantitative Sciences, has been named chair of Vanderbilt’s Department of Biostatistics. He will assume the post Sept. 1.

By VUMC News and Communications
July 20, 2017

Drivers of breast cancer metastasis

Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported.

By Leigh MacMillan
storming night with many bolts of lightning
June 22, 2017

VU scientists report a way to calm the sepsis “storm”

Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis.

By Bill Snyder
Insulin in vials
June 15, 2017

VUMC team’s discovery could lead to new diabetes treatment

By Bill Snyder
April 13, 2017

Vanderbilt University School of Medicine moves to eighth in NIH research funding

Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year.

By John Howser
February 9, 2017

Sanders named to key VUSM Basic Sciences role

Charles Sanders, Ph.D., has been named associate dean for Research in the Basic Sciences of Vanderbilt University School of Medicine.
By Kathy Whitney
February 2, 2017

Gene mutation discovery may hold autism clues: study

Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII.
By Bill Snyder
February 2, 2017

Hasty named to new VUSM Basic Sciences role

Alyssa Hasty, Ph.D., professor of Molecular Physiology and Biophysics, has been named Associate Dean for Faculty Development for Basic Sciences at Vanderbilt University School of Medicine.
By Kathy Whitney
January 26, 2017

Sealy named to VUSM diversity leadership role

Linda Sealy, Ph.D., has been named associate dean for Diversity, Equity and Inclusion for Basic Sciences at Vanderbilt University School of Medicine.
By Kathy Whitney
January 24, 2017

Casagrande recalled as neuroscience pillar, supportive mentor

Vivien Casagrande, Ph.D., a neuroscientist and professor at Vanderbilt University School of Medicine (VUSM) noted for her many contributions to the visual sciences, died peacefully at her home on Saturday, Jan. 21. She was 74.
By Bill Snyder
January 12, 2017

Lindsley’s drug discovery efforts land ASPET Award

Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
By Bill Snyder
December 27, 2016

Investigational new drug for Alzheimer’s scheduled for first study in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
By Craig Boerner
1 … 13 14 15 16 17